AbstractINTRODUCTIONThe Gatekeeper™ is the most recent bulking agent used in the treatment of fecal incontinence with no reported complications. This case reports side effects similar to other bulking agents, namely migration of the prosthesis and perianal abscess.PRESENTATION OF CASEA 52 year old gentleman presented with a history of fecal soiling. He underwent uncomplicated surgery in 2012 for 6 Gatekeeper™ implantations with only temporary improvements. In 2013, endorectal ultrasound revealed prosthesis migration. In 2014, he presented with a perianal abscess which contained one of the prosthesis.DISCUSSIONThe Gatekeeper™, made of the inert Hyexpan, typically implanted in the intersphincteric region, has been used for the treatment of fe...
Background: We sought to compare two synthetic injectable bulking agents, with known efficacy (PTQT<...
Fecal incontinence is a common condition, which leads to impaired quality of life and huge financial...
PURPOSE: Anal bulking agents are injected to pose a stronger obstacle to the involuntary passage of ...
INTRODUCTION: The Gatekeeper™ is the most recent bulking agent used in the treatment of fecal incont...
AbstractINTRODUCTIONThe Gatekeeper™ is the most recent bulking agent used in the treatment of fecal ...
BACKGROUND: Intersphincteric injectable bulking agents are one of the current treatment options for ...
Abstract BACKGROUND: A variety of therapeutic approaches are available for faecal incontinence. I...
Background: Various injectable bulking agents have been used for the treatment of faecal incontinenc...
A variety of therapeutic approaches are available for faecal incontinence. Implantation of Gatekeepe...
BACKGROUND: Various injectable bulking agents have been used for the treatment of faecal incontinen...
Background: Implantation of Gatekeeper™ prostheses presents an option for the treatment of passive ...
Background. We aim to evaluate morphofunctional changes of the sphincter complex after GateKeeper (G...
BACKGROUND:The injection of bulking agents into the anal canal has been reported to help patients wi...
Background: The bulking agent NASHA Dx injected into the submucosal layer is effective in the treatm...
Background Management of fecal incontinence is a priority in acute and critical care to reduce risk ...
Background: We sought to compare two synthetic injectable bulking agents, with known efficacy (PTQT<...
Fecal incontinence is a common condition, which leads to impaired quality of life and huge financial...
PURPOSE: Anal bulking agents are injected to pose a stronger obstacle to the involuntary passage of ...
INTRODUCTION: The Gatekeeper™ is the most recent bulking agent used in the treatment of fecal incont...
AbstractINTRODUCTIONThe Gatekeeper™ is the most recent bulking agent used in the treatment of fecal ...
BACKGROUND: Intersphincteric injectable bulking agents are one of the current treatment options for ...
Abstract BACKGROUND: A variety of therapeutic approaches are available for faecal incontinence. I...
Background: Various injectable bulking agents have been used for the treatment of faecal incontinenc...
A variety of therapeutic approaches are available for faecal incontinence. Implantation of Gatekeepe...
BACKGROUND: Various injectable bulking agents have been used for the treatment of faecal incontinen...
Background: Implantation of Gatekeeper™ prostheses presents an option for the treatment of passive ...
Background. We aim to evaluate morphofunctional changes of the sphincter complex after GateKeeper (G...
BACKGROUND:The injection of bulking agents into the anal canal has been reported to help patients wi...
Background: The bulking agent NASHA Dx injected into the submucosal layer is effective in the treatm...
Background Management of fecal incontinence is a priority in acute and critical care to reduce risk ...
Background: We sought to compare two synthetic injectable bulking agents, with known efficacy (PTQT<...
Fecal incontinence is a common condition, which leads to impaired quality of life and huge financial...
PURPOSE: Anal bulking agents are injected to pose a stronger obstacle to the involuntary passage of ...